News

Drexel University is embarking on a three-year, $5-million multinational collaboration to produce MXene nanomaterials. The ...
The current study sought to explore whether the subcutaneous administration of lymph targeted dendrimers, conjugated with a model chemotherapeutic (methotrexate, MTX), was able to enhance anticancer ...
In a scientific first, researchers from Vanderbilt University and the University of California, San Diego, have generated a ...
Frontiers Events is a rapidly growing calendar management system dedicated to the scheduling of academic events. This includes announcements and invitations, participant listings and search ...
Objective: To examine the association of radiographic progression and disease activity states in patients with rheumatoid arthritis (RA) treated with methotrexate with or without infliximab. Methods: ...
Accurate extraction of molecular representations is a critical step in the drug discovery process. In recent years, significant progress has been made in molecular representation learning methods, ...
Researchers in the Cochrane Collaboration conducted a review of the effects of methotrexate either taken alone or with other disease-modifying anti-rheumatic drugs (DMARDs) for people with rheumatoid ...
Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease-modifying anti-rheumatic drugs: a systematic review and network meta-analysis.
A team of chemists has developed a new type of magnetic molecule that could be the key to storing vast amounts of data on absolutely miniscule drives.
Introduction Methotrexate (MTX) is currently the most frequently used disease-modifying antirheumatic drug (DMARD) in the treatment of rheumatoid arthritis (RA).